MedComms

Next-Generation Integrated Medical Communications: How to Build a Winning Strategy

Building a cohesive communications plan that aligns multiple disciplines, incorporates data-driven storytelling, and coordinates strategic evidence is the foundation of strategic excellence. But developing this plan requires thinking differently. Instead of working in siloes to achieve individual objectives, an integrated medical communications approach highlights collaboration, multidisciplinary stakeholder involvement, and a seamless content approach that drives…...
Read More

Top Stories

Nelson memo

The Nelson Memo: Igniting a Global Open Data

The landscape of scientific research is undergoing a seismic...
Rare diseases

Rare Diseases – An Evolving Medical

A disease is considered rare when it affects fewer than 1 in...

The Paradigm Shift from Traditional Scientific

In the rapidly evolving biopharma landscape, the approach to...
MedComms

Next-Generation Integrated Medical Communications: How to Build a Winning Strategy

Building a cohesive communications plan that aligns multiple disciplines, incorporates data-driven storytelling, and coordinates strategic...
Patient Centricity

The Evolution of Patient Centricity in Pharma (Pre-2020 to 2025): From Aspiration to Embedded Reality

Patient centricity: A defining imperative in healthcare As patient expectations evolve and regulatory bodies demand...
Global Capability Centers

Unlocking the Power of Global Capability Centers (GCCs) in Biopharma: Drive Efficiency, Innovation, and Scientific Excellence

As global biopharma companies face rising demands for efficiency, standardization, and scientific excellence, Global Capability...
Biopharma 2025 Trends

Biopharma Trends 2025: 3 Things to Know Right Now

The global business climate is ever-evolving, and 2025 looks like it may be particularly challenging...
Rare diseases

Rare Diseases – An Evolving Medical Communications Landscape

A disease is considered rare when it affects fewer than 1 in 2,000 people. However...
Involve Medical Affairs in insight management, early phases of clinical trials, etc.

It’s Never Too Soon: How and When to Engage Medical Affairs

Engagement with Medical Affairs is critical at every juncture in the drug development process, with...

Learn more ABOUT our company.